非洲的阿塔克西亚:当前的努力和建议
Anano Nebieridze1,2, Olivier Uwishema1, Yusuf Jaafer Al Tarawneh1,3
1Department of Research and Education, Oli Health Magazine Organization, Kigali, Rwanda.
Annals of medicine and surgery (2012)
|May 8, 2025
概括
由于传染病和粮食短缺,导致移动不稳定的神经系统疾病 - - 动脉动力障碍 (ataxia) 在非洲正在上升. 改善基因测试的准入和患者教育对于更好的诊断和治疗至关重要.
科学领域:
- 神经学 神经学
- 公共卫生 公共卫生
- 遗传学 遗传学 是一个
背景情况:
- 亚达克西亚的患病率在非洲正在增加,由于遗传测试基础设施有限,未被诊断的病例可能很高.
- 与其他地区不同的是,传染病和干旱引起的粮食短缺是非洲氧的主要驱动因素.
- 社会因素加剧了这种情况,突出了健康和环境挑战的复杂相互作用.
研究的目的:
- 分析阿塔克西亚类型,流行病学和社会学因素在非洲环境中的影响.
- 审查现有的国家性病管理战略,重点关注基因测试和神经成像基础设施.
- 发现流行病学研究中的差距,并倡导提高患者和医疗保健工作者意识.
主要方法:
- 亚得克西亚亚型的流行病学分析.
- 审查国家卫生战略和基因测试和神经成像基础设施.
- 评估社会学和环境因素的贡献.
主要成果:
- 传染病和粮食短缺是导致非洲的性衰竭的重要原因.
- 对遗传检测和神经成像技术的有限访问,阻碍了准确的诊断.
- 流行病学数据和公众/专业人士对的认识存在差距.
结论:
- 需要采取多方面的方法,包括增加对诊断基础设施和流行病学研究的资金.
- 加强患者教育和医疗人员培训对于早期检测和管理至关重要.
- 诸如营养支持,患者组和适应性职业治疗等干预措施可以改善患者的生活质量.
相关概念视频
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:19Autism Spectrum Disorder
Autism spectrum disorder (ASD) is a neurodevelopmental condition marked by persistent deficits in social communication and interaction alongside restrictive and repetitive behaviors or interests. ASD is sometimes accompanied by intellectual impairment.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...